First‐Line Lorlatinib in Striatin–Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma: A Case Report and Literature Review
- DOI
- 10.1002/rcr2.70750
- Published
- 2026-09
- Container
- Respirology Case Reports
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/rcr2.70750,
title = {First‐Line Lorlatinib in Striatin–Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma: A Case Report and Literature Review},
author = {Masaru Maebeya and Shinobu Tamura and Takeshi Shono and Takanobu Hoso and Hitomi Tatsuta},
year = {2026},
journal = {Respirology Case Reports},
doi = {10.1002/rcr2.70750},
url = {https://doi.org/10.1002/rcr2.70750}
}RIS
TY - JOUR TI - First‐Line Lorlatinib in Striatin–Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma: A Case Report and Literature Review AU - Masaru Maebeya AU - Shinobu Tamura AU - Takeshi Shono AU - Takanobu Hoso AU - Hitomi Tatsuta PY - 2026 JO - Respirology Case Reports DO - 10.1002/rcr2.70750 UR - https://doi.org/10.1002/rcr2.70750 ER -
APA
Maebeya, M., Tamura, S., Shono, T., Hoso, T., & Tatsuta, H. (2026). First‐Line Lorlatinib in Striatin–Anaplastic Lymphoma Kinase‐Positive Lung Adenocarcinoma: A Case Report and Literature Review. Respirology Case Reports. https://doi.org/10.1002/rcr2.70750
Source records
- crossref · retrieved 2026-09-24T22:15:17.287Z